Effects of sarcolemmal Ca2+ entry, ryanodine function, and kinase inhibitors on a rabbit model of heart failure

International Heart Journal

Volumn 51, Issue 4, 2010, Pages 285-290

  Kijtawornrat, Anusak ^a   Ziolo, Mark T ^a   Nishijima, Yoshinori ^a,b   Roche, Brian M ^b   Hamlin, Robert L ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b QTest Laboratories Inc   (United States)

Author keywords

Calcium; Heart failure; Protein kinase A; QT; Rabbit; Torsades de pointes

Indexed keywords

2 [2 [4 (4 NITROBENZYLOXY)PHENYL]ETHYL]ISOTHIOUREA METHANESULFONATE; CALCIUM; CALCIUM CHANNEL L TYPE; CYCLIC AMP DEPENDENT PROTEIN KINASE; DOFETILIDE; N (2 METHYLAMINOETHYL) 5 ISOQUINOLINESULFONAMIDE; N (6 AMINOHEXYL) 5 CHLORO 1 NAPHTHALENESULFONAMIDE; N [2 [[N [3 (4 CHLOROPHENYL) 2 PROPENYL] N METHYLAMINO]METHYL]PHENYL] N (2 HYDROXYETHYL) 4 METHOXYBENZENESULFONAMIDE; PHOSPHOTRANSFERASE INHIBITOR; PROPRANOLOL; RYANODINE; RYANODINE RECEPTOR; VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CALCIUM TRANSPORT; CHANNEL GATING; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG MECHANISM; ELECTROCARDIOGRAM; ENZYME INHIBITION; HEART FAILURE; HEART MUSCLE FIBER MEMBRANE; HEART VENTRICLE EXTRASYSTOLE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; QT PROLONGATION; RABBIT; RR INTERVAL; SARCOLEMMA; TACHYCARDIA; TORSADE DES POINTES;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; BENZYLAMINES; DISEASE MODELS, ANIMAL; HEART FAILURE; ISOQUINOLINES; MALE; PROTEIN KINASE INHIBITORS; RABBITS; RYANODINE; SULFONAMIDES; THIOUREA; TORSADES DE POINTES; VENTRICULAR PREMATURE COMPLEXES; VERAPAMIL;

EID: 77955835284     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.51.285     Document Type: Article

References (31)

1. Antzelevitch C. Role of transmural dispersion of repolarization in the genesis of drug-induced torsades de pointes. Heart Rhythm 2005; 2: S9-S15. (Review)
2. Belardinelli L, Antzelevitch C, Vos MA. Assessing predictors of drug-induced torsades de pointes. Trends Pharmacol Sci 2003; 24: 619-625. (Review)
3. Volders PG, Vos MA, Szabo B, et al. Progress in the understanding of cardiac early afterdepolarizations and torsades de pointes: time to revise current concepts. Cardiovasc Res 2000; 46: 376-392. (Review)
4. 2+ current. Circ Res 1989; 64: 977-990.
5. Carlsson L, Drews L, Duker G. Rhythm anomalies related to delayed repolarization in vivo: influence of sarcolemmal Ca++ entry and intracellular Ca++ overload. J Pharmacol Exp Ther 1996; 279: 231-239.
6. Viswanathan PC, Rudy Y. Pause induced early after depolarizations in the long QT syndrome: a simulation study. Cardiovasc Res 1999; 42: 530-542.
7. Amran MS, Hashimoto K, Homma N. Effects of sodium-calcium exchange inhibitors, KB-R7943 and SEA0400, on aconitine-induced arrhythmias in guinea pigs in vivo, in vitro, and in computer simulation studies. J Pharmacol Exp Ther 2004; 310: 83-89.
8. 2+ leak in heart failure. Circ Res 2005; 97: 1314-1322.
9. Antos CL, Frey N, Marx SO, et al. Dilated cardiomyopathy and sudden death resulting from constitutive activation of protein kinase a. Circ Res 2001; 89: 997-1004.
10. 2+/calmodulin dependent protein kinase in failing and nonfailing human hearts. Cardiovasc Res 1999; 42: 254-261.
11. Wang J, Liu X, Arneja AS, Dhalla NS. Alterations in protein kinase A and protein kinase C levels in heart failure due to genetic cardiomyopathy. Can J Cardiol 1999; 15: 683-690. (Review)
12. Pogwizd SM, Schlotthauer K, Li L, Yuan W, Bers DM. Arrhythmogenesis and contractile dysfunction in heart failure: Roles of sodium-calcium exchange, inward rectifier potassium current, and residual beta-adrenergic responsiveness. Circ Res 2001; 88: 1159-1167.
13. Anderson ME. QT interval prolongation and arrhythmia: an unbreakableconnection? J Intern Med 2006; 259: 81-90. (Review)
14. Anderson ME, Braun AP, Wu Y, et al. KN-93, an inhibitor of multifunctional Ca++/calmodulin-dependent protein kinase, decreases early afterdepolarizations in rabbit heart. J Pharmacol Exp Ther 1998; 287: 996-1006.
15. Gbadebo TD, Trimble RW, Khoo MS, Temple J, Roden DM, Anderson ME. Calmodulin inhibitor W-7 unmasks a novel electrocardiographic parameter that predicts initiation of torsade de pointes. Circulation 2002; 105: 770-774.
16. Mazur A, Roden DM, Anderson ME. Systemic administration of calmodulin antagonist W-7 or protein kinase A inhibitor H-8 prevents torsade de pointes in rabbits. Circulation 1999; 100: 2437-2442.
17. Kijtawornrat A, Nishijima Y, Roche BM, Keene BW, Hamlin RL. Use of a failing rabbit heart as a model to predict torsadogenicity. Toxicol Sci 2006; 93: 205-212.
18. Carlsson L, Abrahamsson C, Drews L, Duker G. Antiarrhythmic effects of potassium channel openers in rhythm abnormalities related to delayed repolarization. Circulation 1992; 85: 1491-1500.
19. Kijtawornrat A, Ozkanlar Y, Keene BW, Roche BM, Hamlin DM, Hamlin RL. Assessment of drug-induced QT interval prolongation in conscious rabbits. J Pharmacol Toxicol Methods 2006; 53: 168-173.
20. Verduyn SC, Vos MA, Gorgels AP, van der Zande J, Leunissen JD, Wellens HJ. The effect of flunarizine and ryanodine on acquired torsades de pointes arrhythmias in the intact canine heart. J Cardiovasc Electrophysiol 1995; 6: 189-200.
21. Pennock GD, Yun DD, Agarwal PG, Spooner PH, Goldman S. Echocardiographic changes after myocardial infarction in a model of left ventricular diastolic dysfunction. Am J Physiol 1997; 273: H2018-H2209.
22. Tan HL, Hou CJ, Lauer MR, Sung RJ. Electrophysiologic mechanisms of the long QT interval syndromes and torsades de pointes. Ann Intern Med 1995; 122: 701-714. (Review)
23. Milberg P, Reinsch N, Osada N, et al. Verapamil prevents torsade de pointes by reduction of transmural dispersion of repolarization and suppression of early afterdepolarizations in an intact heart model of LQT3. Basic Res Cardiol 2005; 100: 365-371.
24. Marban E, Robinson SW, Wier WG. Mechanisms of arrhythmogenic delayed and early afterdepolarizations in ferret ventricular muscle. J Clin Invest 1986; 78: 1185-1192.
25. Houser SR. When does spontaneous sarcoplasmic reticulum Ca(2+) release cause a triggered arrhythmia? Cellular versus tissue requirements. Circ Res 2000; 87: 725-727.
26. Armoundas AA, Hobai IA, Tomaselli GF, Winslow RL, O'Rourke B. Role of sodium-calcium exchanger in modulating the action potential of ventricular myocytes from normal and failing hearts. Circ Res 2003; 93: 46-53.
27. 2+ and Na+ regulation in normal and failing hearts. J Pharmacol Sci 2006; 100: 315-322. (Review)
28. Weber CR, Piacentino V 3rd, Margulies KB, Bers DM, Houser SR. Calcium influx via I(NCX) is favored in failing human ventricular myocytes. Ann N Y Acad Sci 2002; 976: 478-479.
29. Sipido KR, Varro A, Eisner D. Sodium calcium exchange as a target for antiarrhythmic therapy. Handb Exp Pharmacol 2006; 171: 159-199. (Review)
30. Sag CM, Wadsack DP, Khabbazzadeh S, et al. Calcium/calmodulin-dependent protein kinase II contributes to cardiac arrhythmogenesis in heart failure. Circ Heart Fail 2009; 2: 664-675.
31. 2+ release. Circ Res 2003; 92: 904-911.